BooksTestimonialsInterviewsLibraryArticlesShop Here 

In the News

Pricey hepatitis C drugs threaten health care system

Bing hep C - Mon, 01/11/2016 - 07:29
2 teacher’s aides charged in Antioch classroom child abuse Caption Close With the hepatitis C virus affecting about 3 million persons in the United States, the impact of Gilead’s pricing strategy is real, measurable — and devastating. With a 12-week ...
Categories: In the News

Pricey hepatitis C drugs threaten health care system

Bing hep C - Mon, 01/11/2016 - 07:29
2 teacher’s aides charged in Antioch classroom child abuse Caption Close With the hepatitis C virus affecting about 3 million persons in the United States, the impact of Gilead’s pricing strategy is real, measurable — and devastating. With a 12-week ...
Categories: In the News

Enanta Pharmaceuticals Announces New R&D Initiatives in Hepatitis B Virus and ... - Business Wire (press release)

Google Feed for Hepatitis C Alternative - Mon, 01/11/2016 - 07:01

Enanta Pharmaceuticals Announces New R&D Initiatives in Hepatitis B Virus and ...
Business Wire (press release)
In anticipation of resistance arising due to direct-acting antiviral HCV therapies currently on the market, Enanta has developed an alternative approach to HCV that targets the human host protein cyclophilin. Since cyclophilin inhibitors act as host ...

and more »
Categories: In the News

Hepatitis C: Don’t Squander the Cure

Bing hep C - Mon, 01/11/2016 - 04:58
National Harbor, Md.—With the extraordinary pace of advances in hepatitis C virus (HCV) therapy, you might think that getting most HCV patients to achieve a sustained virologic response (SVR) has become fairly easy. The sobering news is that adherence ...
Categories: In the News

Hepatitis C: Don’t Squander the Cure

Bing hep C - Mon, 01/11/2016 - 04:58
National Harbor, Md.—With the extraordinary pace of advances in hepatitis C virus (HCV) therapy, you might think that getting most HCV patients to achieve a sustained virologic response (SVR) has become fairly easy. The sobering news is that adherence ...
Categories: In the News

Acute Hepatitis C Infection in Young Persons Who Use Drugs

Bing hep C - Mon, 01/11/2016 - 01:35
I appreciate this opportunity to describe what we are calling the "emerging epidemic" of hepatitis C virus (HCV) infection among persons who inject drugs (PWIDs). After several years of plateaued HCV incidence—generally 800-1000 new reported cases of ...
Categories: In the News

Acute Hepatitis C Infection in Young Persons Who Use Drugs

Bing hep C - Mon, 01/11/2016 - 01:35
I appreciate this opportunity to describe what we are calling the "emerging epidemic" of hepatitis C virus (HCV) infection among persons who inject drugs (PWIDs). After several years of plateaued HCV incidence—generally 800-1000 new reported cases of ...
Categories: In the News

Possible Hepatitis C outbreak may affect thousands in Utah

Bing hep C - Sun, 01/10/2016 - 22:13
Jan. 11, 2016 - 0:30 - At least seven thousand people may have contracted the disease after coming in contact with an infected former nurse
Categories: In the News

Time is running out. If you were possibly exposed to hepatitis C, schedule a test

Bing hep C - Sat, 01/09/2016 - 22:47
This is an editorial for 4,660 people. Not just any 4,660 people, however — the 4,660 who still need to be tested for hepatitis C in Ogden and Layton. If you contracted hepatitis at McKay-Dee Hospital or Davis Hospital and Medical Center, you need to know.
Categories: In the News

Utah fears thousands infected in hepatitis C outbreak after exposure to hospital nurse

Bing hep C - Sat, 01/09/2016 - 18:00
More than 7,000 patients at a Utah hospital were potentially exposed to an “outbreak” of hepatitis C after coming into contact with an infected former nurse – but less than half have come in for free testing to find out if they have the disease.
Categories: In the News

Utah fears thousands infected in hepatitis C outbreak after exposure to hospital nurse

Bing hep C - Sat, 01/09/2016 - 18:00
More than 7,000 patients at a Utah hospital were potentially exposed to an “outbreak” of hepatitis C after coming into contact with an infected former nurse – but less than half have come in for free testing to find out if they have the disease.
Categories: In the News

More hepatitis C cases identified after McKay-Dee, Davis hospital exposures

Bing hep C - Fri, 01/08/2016 - 01:59
Positive cases of hepatitis C continue to be recorded as health authorities near completion of their investigation into the outbreak that exposed 7,200 patients to the disease at McKay-Dee Hospital and Davis Hospital and Medical Center, a federal health ...
Categories: In the News

FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers

FDA News - Thu, 01/07/2016 - 11:40
The U.S. Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound.
Categories: In the News

US Marshals seize dietary supplements containing kratom

FDA News - Wed, 01/06/2016 - 14:06
The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency’s request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.
Categories: In the News

Testing finds some hepatitis C cases at Utah hospitals where infected nurse worked

Bing hep C - Wed, 01/06/2016 - 13:09
Two months of testing has identified a rare strain of hepatitis C in the blood of some patients treated at Utah hospitals by a nurse who was later found to have the disease, state health officials said Wednesday. Health officials began free testing in ...
Categories: In the News

The FDA engages stakeholders on opportunities to improve hearing aid usage and innovation

FDA News - Wed, 01/06/2016 - 08:36
The U.S. Food and Drug Administration today announced new efforts to better understand how the agency can appropriately balance patient safety while encouraging advancements in hearing aid technology and access to these devices in the United States. The FDA will convene stakeholders for a public workshop and has re-opened a public comment period on a draft guidance related to the agency’s premarket requirements for hearing aids and personal sound amplification products (PSAPs).
Categories: In the News

FDA strengthens requirements for surgical mesh for the transvaginal repair of pelvic organ prolapse to address safety risks

FDA News - Mon, 01/04/2016 - 08:44
The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) transvaginally, or through the vagina. The FDA issued one order to reclassify these medical devices from class II, which generally includes moderate-risk devices, to class III, which generally includes high-risk devices, and a second order that requires manufacturers to submit a premarket approval (PMA) application to support the safety and effectiveness of surgical mesh for the transvaginal repair of POP.
Categories: In the News

Biocon launches hepatitis-C drug in India - Livemint

Google Feed for Hepatitis C Alternative - Thu, 12/24/2015 - 00:55

Livemint

Biocon launches hepatitis-C drug in India
Livemint
CIMIVIR-L, a once-a-day oral therapy, will offer a convenient, effective and safe alternative to people infected with the Hepatitis-C virus (HCV), the company said. It is estimated that nearly 100,000 people die annually in India from HCV infection and ...
Biocon introduces advanced therapy to treat Hepatitis CEconomic Times

all 44 news articles »
Categories: In the News

FDA approves Zurampic to treat high blood uric acid levels associated with gout

FDA News - Tue, 12/22/2015 - 16:51
The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric acid in the body.
Categories: In the News

FDA approves new orphan drug to treat pulmonary arterial hypertension

FDA News - Tue, 12/22/2015 - 08:44
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
Categories: In the News
Syndicate content